Facebook
Twitter
LinkedIn
ForwardSession Description:
Case conferences have been shown to help team members address knowledge deficiencies, share information and improve patient care. This multispecialty neuroscience meeting is a forum for reviewing clinical cases, lab results, imaging findings, and/or response to treatments of complex cases and rare diagnoses from each quarter. Discussion allows clinicians to review updated best practice treatment guidelines, diagnostic techniques and collaboratively problem-solve complex cases as a department and community.
Target Audience:
Physicians (MD or DO)
Learning Objectives:
After Attending this Activity, Learners Should be Able to:
-Analyze up-to-date treatment approaches for the neurological diseases represented in cases provided.
-Specify and appraise imaging findings and other diagnostic modalities to both expedite and improve care for various neurologic conditions.
- Apply to practice new guidelines, scientific evidence, and best practice recommendations shared through these conferences.
Providing Culturally Appropriate Care which is Free of Implicit Biases (AB 1195 & 241):
Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:
- Doherty EJ, Doherty EJ, Spencer CA, et al. Interdisciplinary views of fNIRS: current advancements, equity challenges, and an agenda for future needs of a diverse fnirs research community. Frontiers in Integrative Neuroscience. 2023;17. doi:10.3389/fnint.2023.1059679. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010439/
- Arredondo MM. Shining a light on cultural neuroscience: recommendations on the use of fNIRS to study how sociocultural contexts shape the brain. Cultur Divers Ethnic Minor Psychol. 2023;29(1):106-117. doi:10.1037/cdp0000469. https://pubmed.ncbi.nlm.nih.gov/3429197
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
No one involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
– Provider Designee/Verification: Kerri Maya, PhD(c), MSL, RN, NPD-BC
- 1.50 AMA PRA Category 1 Credit™
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 AMA PRA Category 1 Credit™ Hour(s)
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health certifies this Live activity was designated for a maximum of 1.50 AMA PRA Category 1 Credit™ Hour(s). Non-physicians should claim only the credit commensurate with the extent of their participation in the activity.